Mr. Arjun Juneja has been instrumental in driving innovation, operational excellence, and global expansion at Mankind Pharma. Since joining in 2009, he has overseen R&D, manufacturing, supply chain, and IT, leading Mankind’s successful IPO in 2023. He spearheaded Mankind Pharma’s entry into the US market and secured USFDA approvals for regulated markets. Under his leadership, state-of-the-art R&D centers in Manesar were established, fostering pharmaceutical advancements. He also transformed Mankind Pharma from a family-run business into a professionally managed institution while overseeing strategic investments through the Mankind Family Office. Recognized among India’s top young business leaders, he serves as Chairman of FICCI’s Pharma Committee.